DCN Dx Revenue
Biotechnology Research • 
Carlsbad, California, United States • 51-100 Employees
DCN Dx revenue & valuation
| Annual revenue | $19,300,000 |
| Revenue per employee | $242,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $61,800,000 |
| Total funding | No funding |
Key Contacts at DCN Dx
Daniel Simpson
Director Of Regulatory Affairs
Charlie Mamrak
Ceo
Thomas Martinache
Associate Director Of Data Management
Cari Stone
Hr Director
Michael L Surmanian
Co-Founder
Company overview
| Headquarters | 3193 Lionshead Ave, Suite 200, Carlsbad, California 92010, US |
| Phone number | +18009646466 |
| Websites | |
| NAICS | 541714 |
| SIC | 807 |
| Keywords | Diagnostics, Nanoparticles, Quantification, Point Of Care, Fluorescent Or Visual Labels, Industrial Design And Engineering, Lateral Flow Education And Training, Manufacturing Transfer And Support, Rapid Test Development, Strategic And Technical Consulting, Lateral Flow, Colloidal Gold, Lateral Flow Readers, Cellulose Nanobeads, Conjugation Kits, Multiplexing & Arraying In Lateral Flow Format |
| Founded | 2005 |
| Employees | 51-100 |
| Socials |
DCN Dx Email Formats
DCN Dx uses 4 email formats. The most common is {first initial}{last name} (e.g., jdoe@dcndx.com), used 54.5% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@dcndx.com | 58.1% |
{first name}{last name} | johndoe@dcndx.com | 34.5% |
{last name}{last name} | doedoe@dcndx.com | 7.3% |
About DCN Dx
DCN Dx specializes in the contract development of rapid point of care tests. We offer a variety of services and products that assist our clients in the design and development of user-centric, high performing diagnostic devices. Contract development of rapid immunoassays is at the core of all that we do at DCN Dx. We focus on lateral flow, flow through, and microfuidic formats. Our staff has unparalleled experience in developing assays with tough specifications, regarding high sensitivity, quantification, multiplexing and reader integration. Our ISO 9001:2015 compliant development process allows for close integration of assay and device development pathways, which ensures the best chance of commercial success for the product. As well as developing the assay itself, DCN Dx's integrated engineering team will design, develop and integrate your entire device. The engineers work closely with our scientists to create cassettes and sample handling devices that enhance the performance of your assay and meet all end-user specifications. We deliver the product, not just the parts. DCN Dx also offers a variety of products and services to assist our clients at any stage of development, including: - Custom, private education and training courses in lateral flow technology, during which we teach the details of how to develop and manufacture rapid assays. - Consulting services to assist with any aspect of rapid assay development, manufacturing, regulation and commercialization. - Custom protein-protein, protein-particle, small molecule-protein and small molecule- particle conjugations. - Lateral flow material starter kits, conjugation kits, reagents, cassettes and materials for use during rapid assay development. DCN Dx represents a single source that can help you manage and deliver completely validated assay platforms. CONTACT US: www.dcndx.com info@dcndx.com (760) 804-3886
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
DCN Dx has 50 employees across 15 departments.
Departments
Number of employees
DCN Dx Tech Stack
Discover the technologies and tools that power DCN Dx's digital infrastructure, from frameworks to analytics platforms.
Security
WordPress plugins
Miscellaneous
Affiliate programs
Cookie compliance
JavaScript libraries
JavaScript libraries
WordPress plugins
JavaScript libraries
JavaScript libraries
WordPress themes
Page builders
Canada
Italy
Frequently asked questions
4.8
40,000 users
